Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Journey and Relevant Influences for the 15-month Pathway Addressing the Pediatric Radiology Workforce Shortage.

Pediatric radiology·2025
Same author

Photon-counting CT yields superior abdominopelvic image quality at lower radiation and iodinated contrast doses.

Pediatric radiology·2025
Same author

Expert panel on monitoring radiation doses from recurrent medical diagnostic procedures: Sixth Gilbert W. Beebe Webinar.

Journal of applied clinical medical physics·2025
Same author

AAPM Truth-based CT (TrueCT) reconstruction grand challenge.

Medical physics·2025
Same author

Ranking the Relative Importance of Image Quality Features in CT by Consensus Survey.

Journal of the American College of Radiology : JACR·2024
Same author

Multi-institutional Protocol Guidance for Pediatric Photon-counting CT.

Radiology·2024

Related Experiment Video

Updated: Jun 26, 2026

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

Patient-specific dose estimation for pediatric chest CT.

Xiang Li, Ehsan Samei, W Paul Segars

    Medical Physics
    |January 30, 2009
    PubMed
    Summary
    This summary is machine-generated.

    Pediatric CT radiation dose varies significantly even for patients of similar size. This study developed patient-specific models to estimate organ dose, improving risk assessment and protocol optimization.

    More Related Videos

    Whole-body PET/MRI of Pediatric Patients: The Details That Matter
    10:02

    Whole-body PET/MRI of Pediatric Patients: The Details That Matter

    Published on: December 19, 2017

    Related Experiment Videos

    Last Updated: Jun 26, 2026

    A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
    09:49

    A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

    Published on: April 24, 2020

    Whole-body PET/MRI of Pediatric Patients: The Details That Matter
    10:02

    Whole-body PET/MRI of Pediatric Patients: The Details That Matter

    Published on: December 19, 2017

    Area of Science:

    • Medical Physics
    • Radiological Sciences
    • Computational Biology

    Background:

    • Current pediatric CT dose estimation methods are generic, using limited patient models that don't capture anatomical variability.
    • Existing models fail to account for differences in patient anatomy and body habitus within the same size/age group.

    Discussion:

    • This study created detailed, patient-specific computational models from actual pediatric CT data for dose estimation.
    • Monte Carlo simulations were used to calculate organ and effective doses for seven pediatric patients undergoing chest CT.
    • Organ dose variations were found to be small for large organs but significant for smaller or indirectly exposed organs.

    Key Insights:

    • Normalized effective dose showed a weak negative correlation with body weight (r=-0.80).
    • Normalized lung and heart doses strongly correlated with mid-chest diameter (r=-0.99 and r=-0.93, respectively), enabling patient-specific dose estimation.
    • Significant organ dose variability exists within pediatric CT patients of the same size/protocol group.

    Outlook:

    • Developed patient-specific models and correlation methods can enhance pediatric CT risk assessment.
    • Findings support optimizing pediatric CT scan protocols and developing tailored dose reduction strategies.
    • This work provides a novel approach for patient-specific organ dose estimation in pediatric CT.